フォロー
Taslim A. Al-Hilal
Taslim A. Al-Hilal
Associate Professor, Departments of Molecular Pharmaceutics and BME, The University of Utah
確認したメール アドレス: pharm.utah.edu
タイトル
引用先
引用先
Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption
H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan
International journal of pharmaceutics 544 (1), 285-296, 2018
1422018
Oral drug delivery systems using chemical conjugates or physical complexes
TA Al-Hilal, F Alam, Y Byun
Advanced drug delivery reviews 65 (6), 845-864, 2013
1132013
Engineered nanodelivery systems to improve DNA vaccine technologies
M Lim, AZM Badruddoza, J Firdous, M Azad, A Mannan, TA Al-Hilal, ...
Pharmaceutics 12 (1), 30, 2020
892020
High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives
JW Park, OC Jeon, SK Kim, TA Al-Hilal, SJ Jin, HT Moon, VC Yang, ...
Journal of controlled release 148 (3), 317-326, 2010
622010
Strategies for non-invasive delivery of biologics
SW Chung, TA Hil-lal, Y Byun
Journal of drug targeting 20 (6), 481-501, 2012
612012
Oligomeric bile acid-mediated oral delivery of low molecular weight heparin
TA Al-Hilal, J Park, F Alam, SW Chung, JW Park, K Kim, IC Kwon, IS Kim, ...
Journal of controlled release 175, 17-24, 2014
552014
Functional transformations of bile acid transporters induced by high-affinity macromolecules
TA Al-Hilal, SW Chung, F Alam, J Park, KE Lee, H Jeon, K Kim, IC Kwon, ...
Scientific reports 4 (1), 4163, 2014
542014
Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid
F Alam, TA Al-Hilal, SW Chung, D Seo, F Mahmud, HS Kim, SY Kim, ...
Biomaterials 35 (24), 6543-6552, 2014
512014
Antiangiogenic and anticancer effect of an orally active low molecular weight heparin conjugates and its application to lung cancer chemoprevention
J Kim, TA Al-Hilal, SW Chung, SY Kim, GH Ryu, WC Son, Y Byun
Journal of controlled release 199, 122-131, 2015
432015
LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways
SW Chung, SM Bae, M Lee, TA Al-Hilal, CK Lee, JK Kim, IS Kim, SY Kim, ...
Biomaterials 37, 271-278, 2015
422015
Transplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis
JY Shin, JH Jeong, J Han, SH Bhang, GJ Jeong, MR Haque, TA Al-Hilal, ...
Tissue Engineering Part A 21 (5-6), 1024-1035, 2015
382015
Xenotransplantation of layer-by-layer encapsulated non-human primate islets with a specified immunosuppressive drug protocol
MR Haque, J Kim, H Park, HS Lee, KW Lee, TA Al-Hilal, JH Jeong, ...
Journal of Controlled Release 258, 10-21, 2017
362017
Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates
OC Jeon, SR Hwang, TA Al-Hilal, JW Park, HT Moon, S Lee, JH Park, ...
Pharmaceutical research 30, 959-967, 2013
352013
Anticoagulant efficacy of solid oral formulations containing a new heparin derivative
JW Park, OC Jeon, SK Kim, TA Al-Hilal, HT Moon, CY Kim, Y Byun
Molecular pharmaceutics 7 (3), 836-843, 2010
302010
Cancer-on-a-chip: models for studying metastasis
X Zhang, M Karim, MM Hasan, J Hooper, R Wahab, S Roy, TA Al-Hilal
Cancers 14 (3), 648, 2022
292022
Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine
F Mahmud, OC Jeon, TA Al-Hilal, S Kweon, VC Yang, DS Lee, Y Byun
Molecular Pharmaceutics 12 (6), 1911-1920, 2015
292015
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application
TA Al-Hilal, A Keshavarz, H Kadry, B Lahooti, A Al-Obaida, Z Ding, W Li, ...
Lab on a Chip 20 (18), 3334-3345, 2020
282020
A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway
JU Choi, SW Chung, TA Al-Hilal, F Alam, J Park, F Mahmud, JH Jeong, ...
Biomaterials 139, 56-66, 2017
282017
Targeting prion-like protein doppel selectively suppresses tumor angiogenesis
TA Al-Hilal, SW Chung, JU Choi, F Alam, J Park, SW Kim, SY Kim, ...
The Journal of clinical investigation 126 (4), 1251-1266, 2016
272016
Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis
SR Hwang, DH Seo, TA Al-Hilal, OC Jeon, JH Kang, SH Kim, HS Kim, ...
Journal of controlled release 163 (3), 374-384, 2012
272012
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20